Resources & Insights
Explore the peer-reviewed science, conference presentations, and market intelligence behind DeepCyte's AI-powered single-cell metabolomics platform.
Market Intelligence
News & Press Releases
Analysis on how single-cell methodologies and AI mapping mitigate early toxicity risks to control clinical costs.
Press Release
DeepCyte Launches World's First Single-Cell Mechanistic Toxicity Atlas as Enterprise Pharma Pilots Advance
Source: DeepCyte
Press Release
DeepCyte Raises $1.5M to Bring Single-Cell AI Toxicology to Drug Development
Source: DeepCyte
Interview
The Expanding Frontier of Metabolomics in Precision Medicine: Spatial, Single-Cell, Real-Time, and Beyond
Source: Inside Precision Medicine
Peer-Reviewed Science
Research & Publications
Key publications demonstrating how single-cell metabolomics maps cellular changes to predict toxicity.
Research Paper
HT SpaceM: A high-throughput and reproducible method for small-molecule single-cell metabolomics
Perspective
Metabolomics across scales: from single cells to population studies
Perspective
How to build the virtual cell with artificial intelligence: Priorities and opportunities
Conference Presentations
Scientific Presentations
DeepCyte CEO Theodore Alexandrov & CTO Shawn Owens presenting our single-cell analytical workflows at prominent global drug toxicity & safety venues.
Abstract
DeeTox: Single-Cell Mechanistic AI Predicting Toxicity Mechanisms for Immune Cells
EuroTox: Theodore Alexandrov
Abstract
High-Throughput Single-Cell Metabolomics for Mechanism-Resolved Toxicology
EuroTox: Shawn Owens
Presentation
Spatial Single-Cell Metabolomics
HKU Symposium: Theodore Alexandrov